Literature DB >> 19777506

Reproducibility of serial whole-brain MR spectroscopic imaging.

A A Maudsley1, C Domenig, S Sheriff.   

Abstract

The reproducibility of serial measurements using a volumetric proton MR Spectroscopic Imaging (MRSI) acquisition implemented at 3 Tesla and with lipid suppression by inversion-recovery has been evaluated. Data were acquired from two subjects at five time points, and processed using fully-automated procedures that included rigid registration between studies. These data were analyzed to determine coefficients of variance (COV) for each metabolite and for metabolite ratio images based on an individual voxel analysis, as well as for average and grey-matter and white-matter values from atlas-defined brain regions. The volumetric MRSI acquisition was found to obtain data of sufficient quality for analysis over 70 +/- 6% of the total brain volume, and spatial distributions of the resultant COV values were found to reflect the known distributions of susceptibility-induced magnetic field inhomogeneity. Median values of the resultant voxel-based COVs were 6.2%, 7.2%, and 9.7% for N-acetylaspartate, creatine, and choline respectively. The corresponding mean values obtained following averaging over lobar-scale brain regions within the cerebrum were 3.5%, 3.7%, and 5.2%. These results indicate that longitudinal volumetric MRSI studies with post-acquisition registration can provide an intra-subject reproducibility for voxel-based analyses that is comparable to previously-reported single-voxel MRS measurements, while additionally enabling increased sensitivity by averaging over larger tissue volumes. 2009 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19777506      PMCID: PMC2917802          DOI: 10.1002/nbm.1445

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  30 in total

Review 1.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

2.  Design and construction of a realistic digital brain phantom.

Authors:  D L Collins; A P Zijdenbos; V Kollokian; J G Sled; N J Kabani; C J Holmes; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-06       Impact factor: 10.048

3.  Automated spectral analysis III: application to in vivo proton MR spectroscopy and spectroscopic imaging.

Authors:  B J Soher; K Young; V Govindaraju; A A Maudsley
Journal:  Magn Reson Med       Date:  1998-12       Impact factor: 4.668

4.  A systematic study of the lactate lineshape in PRESS-localized proton spectroscopy.

Authors:  I Marshall; J Wild
Journal:  Magn Reson Med       Date:  1998-07       Impact factor: 4.668

5.  Combining spatial extent and peak intensity to test for activations in functional imaging.

Authors:  J B Poline; K J Worsley; A C Evans; K J Friston
Journal:  Neuroimage       Date:  1997-02       Impact factor: 6.556

6.  Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures.

Authors:  C Studholme; D L Hill; D J Hawkes
Journal:  Med Phys       Date:  1997-01       Impact factor: 4.071

7.  Removal of lipid artifacts in 1H spectroscopic imaging by data extrapolation.

Authors:  C I Haupt; N Schuff; M W Weiner; A A Maudsley
Journal:  Magn Reson Med       Date:  1996-05       Impact factor: 4.668

8.  Reproducibility of proton MR spectroscopic imaging findings.

Authors:  G Tedeschi; A Bertolino; G Campbell; A S Barnett; J H Duyn; P K Jacob; C T Moonen; J R Alger; G Di Chiro
Journal:  AJNR Am J Neuroradiol       Date:  1996 Nov-Dec       Impact factor: 3.825

9.  Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.

Authors:  A Simmons; M Smail; E Moore; S C Williams
Journal:  Magn Reson Imaging       Date:  1998-04       Impact factor: 2.546

10.  Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy.

Authors:  S Kalra; N R Cashman; A Genge; D L Arnold
Journal:  Neuroreport       Date:  1998-06-01       Impact factor: 1.837

View more
  41 in total

Review 1.  Whole Brain ¹H-Spectroscopy: A Developing Technique for Advanced Analysis of Cerebral Metabolism.

Authors:  X-Q Ding; H Lanfermann
Journal:  Clin Neuroradiol       Date:  2015-07-09       Impact factor: 3.649

2.  Fully automated atlas-based method for prescribing 3D PRESS MR spectroscopic imaging: Toward robust and reproducible metabolite measurements in human brain.

Authors:  Wei Bian; Yan Li; Jason C Crane; Sarah J Nelson
Journal:  Magn Reson Med       Date:  2017-05-03       Impact factor: 4.668

Review 3.  Quantitative proton magnetic resonance spectroscopy and spectroscopic imaging of the brain: a didactic review.

Authors:  Jeffry R Alger
Journal:  Top Magn Reson Imaging       Date:  2010-04

4.  Role of very high order and degree B0 shimming for spectroscopic imaging of the human brain at 7 tesla.

Authors:  Jullie W Pan; Kai-Ming Lo; Hoby P Hetherington
Journal:  Magn Reson Med       Date:  2011-12-28       Impact factor: 4.668

Review 5.  Utility of magnetic resonance spectroscopic imaging for human epilepsy.

Authors:  Jullie W Pan; Ruben I Kuzniecky
Journal:  Quant Imaging Med Surg       Date:  2015-04

6.  Comparison of reproducibility of single voxel spectroscopy and whole-brain magnetic resonance spectroscopy imaging at 3T.

Authors:  Yue Zhang; Edward Taub; Nouha Salibi; Gitendra Uswatte; Andrew A Maudsley; Sulaiman Sheriff; Brent Womble; Victor W Mark; David C Knight
Journal:  NMR Biomed       Date:  2018-02-13       Impact factor: 4.044

7.  Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.

Authors:  D J Rigotti; A Gass; L Achtnichts; M Inglese; J S Babb; Y Naegelin; J Hirsch; M Amann; L Kappos; O Gonen
Journal:  Mult Scler       Date:  2011-09-15       Impact factor: 6.312

8.  Whole-brain magnetic resonance spectroscopic imaging measures are related to disability in ALS.

Authors:  Charlotte J Stagg; Steven Knight; Kevin Talbot; Mark Jenkinson; Andrew A Maudsley; Martin R Turner
Journal:  Neurology       Date:  2013-01-16       Impact factor: 9.910

Review 9.  Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imaging.

Authors:  Sarah J Nelson; Eugene Ozhinsky; Yan Li; Il woo Park; Jason Crane
Journal:  J Magn Reson       Date:  2013-02-08       Impact factor: 2.229

10.  Application of volumetric MR spectroscopic imaging for localization of neocortical epilepsy.

Authors:  Andrew A Maudsley; Claudia Domenig; R Eugene Ramsay; Brian C Bowen
Journal:  Epilepsy Res       Date:  2009-11-17       Impact factor: 3.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.